Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Research findings have suggested higher failure rates in oral contraceptive (OC) users who are heavy; however, new results from a retrospective analysis of Phase III efficacy data of a popular ethinyl estradiol/norgestimate formulation (Ortho Tri-Cyclen Lo, Ortho McNeil Pharmaceutical; Raritan, NJ) indicate that it is not associated with an increased risk of pregnancy in such women.

Study looks at weight impact on OC efficacy